Trial intelligence / Profile preview

Peri-operative Mirtazapine for Post Mastectomy Pain

NCT06499090Phase 1Completed

Sponsor
Assiut University
Start
Mar 2024
Primary completion
Dec 2025
Modality
Small Molecules
Countries
1
01

Overview

Phase 1, randomised trial in Post-mastectomy pain syndrome (PMPS) comparing Mirtazapine group with Placebo group (2 arms). Primary endpoint: Cumulative postoperative 24 h morphine consumption. Started Mar 2024; status: completed.

02

Drugs

mirtazapine
03

Conditions

Post-mastectomy pain syndrome (PMPS)

Beyond the preview

Go deeper on NCT06499090.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT06499090.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call